Literature DB >> 29508560

Brain structure alterations in depression: Psychoradiological evidence.

Fei-Fei Zhang1, Wei Peng1, John A Sweeney1,2, Zhi-Yun Jia1,3, Qi-Yong Gong1,4.   

Abstract

Depression is the leading cause of disability around the world, but little is known about its pathology. Currently, the diagnosis of depression is made based on clinical manifestations, with little objective evidence. Magnetic resonance imaging (MRI) has been used to investigate the pathological changes in brain anatomy associated with this disorder. MRI can identify structural alterations in depressive patients in vivo, which could make considerable contributions to clinical diagnosis and treatment. Numerous studies that focused on gray and white matter have found significant brain region alterations in major depressive disorder patients, such as in the frontal lobe, hippocampus, temporal lobe, thalamus, striatum, and amygdala. The results are inconsistent and controversial because of the different demographic and clinical characteristics. However, some regions overlapped; thus, we think that there may be a "hub" in MDD and that an impairment in these regions contributes to disease severity. Brain connections contain both structural connections and functional connections, which reflect disease from a different view and support that MDD may be caused by the interaction of multiple brain regions. According to previous reports, significant circuits include the frontal-subcortical circuit, the suicide circuit, and the reward circuit. As has been recognized, the pathophysiology of major depressive disorder is complex and changeable. The current review focuses on the significant alterations in the gray and white matter of patients with the depressive disorder to generate a better understanding of the circuits. Moreover, identifying the nuances of depressive disorder and finding a biomarker will make a significant contribution to the guidance of clinical diagnosis and treatment.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  Psychoradiology, diffusion MRI; magnetic resonance imaging; major depressive disorder; structure MRI

Mesh:

Year:  2018        PMID: 29508560      PMCID: PMC6489983          DOI: 10.1111/cns.12835

Source DB:  PubMed          Journal:  CNS Neurosci Ther        ISSN: 1755-5930            Impact factor:   5.243


  101 in total

Review 1.  The limbic thalamus.

Authors:  Katherine H Taber; Christopher Wen; Asra Khan; Robin A Hurley
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2004       Impact factor: 2.198

2.  Impaired frontothalamic circuitry in suicidal patients with depression revealed by diffusion tensor imaging at 3.0 T.

Authors:  Zhiyun Jia; Yuqing Wang; Xiaoqi Huang; Weihong Kuang; Qizhu Wu; Su Lui; John A Sweeney; Qiyong Gong
Journal:  J Psychiatry Neurosci       Date:  2014-05       Impact factor: 6.186

3.  Hippocampal and subcortical alterations of first-episode, medication-naïve major depressive disorder with panic disorder patients.

Authors:  Chien-Han Lai
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2014-04-01       Impact factor: 2.198

4.  Structural equation modeling and principal component analysis of gray matter volumes in major depressive and bipolar disorders: differences in latent volumetric structure.

Authors:  Ping-Hong Yeh; Hongtu Zhu; Mark A Nicoletti; John P Hatch; Paolo Brambilla; Jair C Soares
Journal:  Psychiatry Res       Date:  2010-11-03       Impact factor: 3.222

5.  Glucocorticoids activate a synapse weakening pathway culminating in tau phosphorylation in the hippocampus.

Authors:  Jee Hyun Yi; Christopher Brown; Garry Whitehead; Thomas Piers; Young Seok Lee; Celia Martinez Perez; Philip Regan; Daniel J Whitcomb; Kwangwook Cho
Journal:  Pharmacol Res       Date:  2017-04-14       Impact factor: 7.658

Review 6.  The cortico-basal ganglia integrative network: the role of the thalamus.

Authors:  Suzanne N Haber; Roberta Calzavara
Journal:  Brain Res Bull       Date:  2008-10-23       Impact factor: 4.077

7.  Differences between suicide attempters and nonattempters in depressed older patients: depression severity, white-matter lesions, and cognitive functioning.

Authors:  Natalie Sachs-Ericsson; Jennifer L Hames; Thomas E Joiner; Elizabeth Corsentino; Nicole C Rushing; Emily Palmer; Ian H Gotlib; Edward A Selby; Steven Zarit; David C Steffens
Journal:  Am J Geriatr Psychiatry       Date:  2013-02-06       Impact factor: 4.105

8.  Increased suicide attempts in young depressed patients with abnormal temporal-parietal-limbic gray matter volume.

Authors:  Hongjun Peng; Kai Wu; Jie Li; Haochen Qi; Shengwen Guo; Minyue Chi; Xiaoming Wu; Yangbo Guo; Yuling Yang; Yuping Ning
Journal:  J Affect Disord       Date:  2014-04-24       Impact factor: 4.839

9.  Brain volumetric and metabolic correlates of electroconvulsive therapy for treatment-resistant depression: a longitudinal neuroimaging study.

Authors:  M Cano; I Martínez-Zalacaín; Á Bernabéu-Sanz; O Contreras-Rodríguez; R Hernández-Ribas; E Via; A de Arriba-Arnau; V Gálvez; M Urretavizcaya; J Pujol; J M Menchón; N Cardoner; C Soriano-Mas
Journal:  Transl Psychiatry       Date:  2017-02-07       Impact factor: 6.222

10.  High-field magnetic resonance imaging of structural alterations in first-episode, drug-naive patients with major depressive disorder.

Authors:  Z Chen; W Peng; H Sun; W Kuang; W Li; Z Jia; Q Gong
Journal:  Transl Psychiatry       Date:  2016-11-08       Impact factor: 6.222

View more
  50 in total

1.  Imaging connectomics in depression.

Authors:  Ming-Rui Xia; Tian-Mei Si; Yong He
Journal:  CNS Neurosci Ther       Date:  2018-11       Impact factor: 5.243

Review 2.  Brain structure alterations in depression: Psychoradiological evidence.

Authors:  Fei-Fei Zhang; Wei Peng; John A Sweeney; Zhi-Yun Jia; Qi-Yong Gong
Journal:  CNS Neurosci Ther       Date:  2018-03-05       Impact factor: 5.243

Review 3.  Antepartum Depression and Preterm Birth: Pathophysiology, Epidemiology, and Disparities due to structural racism.

Authors:  Edmond D Shenassa; Lea G Widemann; Cole D Hunt
Journal:  Curr Psychiatry Rep       Date:  2021-02-25       Impact factor: 5.285

4.  Abnormal voxel-wise whole-brain functional connectivity in first-episode, drug-naïve adolescents with major depression disorder.

Authors:  Ruiping Zheng; Yuan Chen; Yu Jiang; Bingqian Zhou; Shaoqiang Han; Yarui Wei; Caihong Wang; Jingliang Cheng
Journal:  Eur Child Adolesc Psychiatry       Date:  2022-03-23       Impact factor: 4.785

Review 5.  Neuroanatomical, Biochemical, and Functional Modifications in Brain Induced by Treatment with Antidepressants.

Authors:  Nikhat J Siddiqi; Maria de Lourdes Pereira; Bechan Sharma
Journal:  Mol Neurobiol       Date:  2022-03-29       Impact factor: 5.590

Review 6.  Mechanisms affecting brain remodeling in depression: do all roads lead to impaired fibrinolysis?

Authors:  Silvia Hoirisch-Clapauch
Journal:  Mol Psychiatry       Date:  2021-08-17       Impact factor: 15.992

7.  Association between tDCS computational modeling and clinical outcomes in depression: data from the ELECT-TDCS trial.

Authors:  Paulo J C Suen; Sarah Doll; Marcelo C Batistuzzo; Geraldo Busatto; Lais B Razza; Frank Padberg; Eva Mezger; Lucia Bulubas; Daniel Keeser; Zhi-De Deng; Andre R Brunoni
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2020-04-11       Impact factor: 5.270

8.  Distribution of the Noradrenaline Innervation and Adrenoceptors in the Macaque Monkey Thalamus.

Authors:  Isabel Pérez-Santos; Nicola Palomero-Gallagher; Karl Zilles; Carmen Cavada
Journal:  Cereb Cortex       Date:  2021-07-29       Impact factor: 5.357

9.  Associations between brain volumetry and relaxometry signatures and the Edmonton Frail Scale in frailty.

Authors:  Chunmei Li; Yuhui Chen; Pu-Yeh Wu; Bing Wu; Tao Gong; Hua Wang; Min Chen
Journal:  Quant Imaging Med Surg       Date:  2021-06

10.  Reduced Brain Gray Matter Volume in Patients With First-Episode Major Depressive Disorder: A Quantitative Meta-Analysis.

Authors:  Ruiping Zheng; Yong Zhang; Zhengui Yang; Shaoqiang Han; Jingliang Cheng
Journal:  Front Psychiatry       Date:  2021-07-01       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.